MedPath

To study the effects of pomegranate gel in the treatment of gum disease

Phase 2
Completed
Registration Number
CTRI/2020/10/028516
Lead Sponsor
Alina Pauly
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Patients with at least two sites per quadrant, excepting third molars, with 4ââ?¬â??6 mm probing pocket depth.

Patients who have not undergone any periodontal therapy in the previous 6 months.

Patients who are systemically healthy.

Patients exhibiting good oral hygiene.

Patients who are compliant and are able to attend follow up.

Exclusion Criteria

Pregnant and lactating women.

Presence of allergic reactions to the agent used in the study.

Uncontrolled systemic conditions such as diabetes, hypertension etc.

Smokers.

Patients who have taken any medication within the last 6 months which may alter the periodontal status.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in probing pocket depth (PPD) and clinical attachment level (CAL) will be observed in the experimental and control sites.Timepoint: At the baseline visit, 3 months and 6 months.
Secondary Outcome Measures
NameTimeMethod
Changes in plaque index(PI) scores, gingival index (GI) scores and bleeding index (BI) scores will be documented.Timepoint: At the baseline visit, 3 months and 6 months.
© Copyright 2025. All Rights Reserved by MedPath